Acceleron Pharma

Investors/Media

Press Releases

Date Title and Summary View
Toggle Summary Start-Up: Acceleron Pharma, Inc.-Releasing the Brakes on Bone and Muscle Growth
Start-Up: Acceleron Pharma, Inc.-Releasing the Brakes on Bone and Muscle Growth Start-Up: June 1, 2007
View HTML
Toggle Summary Acceleron Pharma’s ACE-031 Increases Muscle Mass and Strength in Preclinical Studies
Novel Compound Shown to be Promising Potential Therapy for Multiple Diseases with Unmet Medical Need
View HTML
Toggle Summary Acceleron Pharma Appoints James Desiderio, Ph.D. as Vice President, Program Managemen
Dr. Desiderio’s Expertise in Managing Development Programs in Companies with Multiple Products is Valuable as Acceleron’s Pipeline Rapidly Expands and Advances
View HTML
Toggle Summary GEN: Acceleron Takes on Bone & Muscle Repair
Genetic Engineering & Biotechnology News April 1, 2007 (Vol. 27, No. 7)
View HTML
Toggle Summary Acceleron Pharma Appoints Robert Steininger as Senior Vice President, Manufacturing
Mr. Steininger’s Expertise in Building Manufacturing Organizations is a Key Addition to the Acceleron Management Team
View HTML
Toggle Summary Acceleron Pharma to Present at the Cowen 27th Annual Health Care Conference
Acceleron Pharma to Present at the Cowen 27th Annual Health Care Conference CAMBRIDGE, MA – March 7, 2007 – Acceleron Pharma, Inc., a biopharmaceutical company developing novel biotherapeutics, today announced that Steven Ertel, Vice President Business Development, will provide a corporate
View HTML
Toggle Summary Acceleron Pharma to Present at the Rodman & Renshaw 8th Annual Healthcare Conference
Acceleron Pharma to Present at the Rodman & Renshaw 8th Annual Healthcare Conference CAMBRIDGE, MA – November 3, 2006 – Acceleron Pharma, Inc., a biopharmaceutical company developing regenerative therapeutics, today announced that Glenn Batchelder, Chief Executive Officer, will provide a corporate
View HTML
Toggle Summary Acceleron Pharma to Present at the MBC’s MASS Opportunities Conference
Acceleron Pharma to Present at the MBC’s MASS Opportunities Conference CAMBRIDGE, MA – October 30, 2006 – Acceleron Pharma, Inc., a biopharmaceutical company involved in the development of regenerative therapeutics, today announced that Glenn Batchelder, Chief Executive Officer, will provide a
View HTML
Toggle Summary Acceleron Pharma Presents ACE-011 Preclinical Data Demonstrating Both Anabolic and Anti-Resorptive Properties
Novel Approach Represents Significant Advance for the Treatment of Bone Loss
View HTML
Toggle Summary Acceleron Pharma to Present ACE-011 Preclinical Data at the Annual Meeting of the American Society for Bone and Mineral Research
Preclinical Data Demonstrate Dual Activity of ACE-011
View HTML